Literature DB >> 20581121

Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007.

Catherine Dumartin1, François L'Hériteau, Muriel Péfau, Xavier Bertrand, Pascal Jarno, Sandrine Boussat, Pacôme Angora, Ludivine Lacavé, Karine Saby, Anne Savey, Florence Nguyen, Anne Carbonne, Anne-Marie Rogues.   

Abstract

OBJECTIVES: Antibiotic use in French hospitals is among the highest in Europe. A study was carried out to describe antibiotic consumption for inpatients at hospital and at ward levels.
METHODS: Data were voluntarily collected retrospectively by 530 hospitals accounting for approximately 40 million patient-days (PD) on the following: antibacterials for systemic use [J01 class of the WHO Anatomical Therapeutic Chemical (ATC) classification, defined daily doses (DDD) system, 2007], rifampicin and oral imidazole derivatives, expressed in number of DDD and number of PD in 2007. Consumption was expressed in DDD/1000 PD.
RESULTS: Median antibiotic use ranged from 60 DDD/1000 PD in long-term care (LTC) and psychiatric hospitals to 633 DDD/1000 PD in teaching hospitals. Penicillins and beta-lactamase inhibitors combinations were the most frequently used antibiotics, accounting for 26% of total use in cancer hospitals to 40% in LTC/psychiatric hospitals. Glycopeptides and carbapenems were mostly used in cancer and teaching hospitals. Level of consumption and pattern of use differed according to clinical ward from 60 DDD/1000 PD in psychiatric wards up to 1466 DDD/1000 PD in intensive care units (ICUs). In medicine, surgery, ICU and rehabilitation wards, fluoroquinolones accounted for 13%-19% of the total use.
CONCLUSIONS: This multicentre survey provided detailed information on antibiotic use in a large sample of hospitals and wards, allowing relevant comparisons and benchmarking. Analysis of consumption at the ward level should help hospitals to target practice audits to improve antibiotic use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20581121     DOI: 10.1093/jac/dkq228

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  26 in total

1.  Selection of hospital antimicrobial prescribing quality indicators: a consensus among German antibiotic stewardship (ABS) networkers.

Authors:  J Thern; K de With; R Strauss; M Steib-Bauert; N Weber; W V Kern
Journal:  Infection       Date:  2013-12-11       Impact factor: 3.553

2.  In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario?

Authors:  Aida Ripoll; Fernando Baquero; Angela Novais; Mario J Rodríguez-Domínguez; Maria-Carmen Turrientes; Rafael Cantón; Juan-Carlos Galán
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

3.  Hospital statistics for antibiotics: defined versus prescribed daily dose.

Authors:  C Gagliotti; E Ricchizzi; R Buttazzi; F Tumietto; D Resi; M L Moro
Journal:  Infection       Date:  2014-06-29       Impact factor: 3.553

4.  Surveillance of Antibiotic Use and Resistance in Intensive Care Units (SARI).

Authors:  Cornelius Remschmidt; Sandra Schneider; Elisabeth Meyer; Barbara Schroeren-Boersch; Petra Gastmeier; Frank Schwab
Journal:  Dtsch Arztebl Int       Date:  2017-12-15       Impact factor: 5.594

5.  Quantifying the effect of in-hospital antimicrobial use on the development of colistin-resistant Acinetobacter baumannii strains: a time series analysis.

Authors:  Rania Kousovista; Christos Athanasiou; Konstantinos Liaskonis; Olga Ivopoulou; Vangelis D Karalis
Journal:  Eur J Hosp Pharm       Date:  2022-03

6.  Is nationwide special campaign on antibiotic stewardship program effective on ameliorating irrational antibiotic use in China? Study on the antibiotic use of specialized hospitals in China in 2011-2012.

Authors:  Xiao-Xu Zou; Zi Fang; Rui Min; Xue Bai; Yang Zhang; Dong Xu; Peng-Qian Fang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-06-18

7.  A 6-year antifungal stewardship programme in a teaching hospital.

Authors:  V Mondain; F Lieutier; L Hasseine; M Gari-Toussaint; M Poiree; C Lions; C Pulcini
Journal:  Infection       Date:  2013-03-06       Impact factor: 3.553

8.  Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009.

Authors:  Kyungwon Lee; Mi-Na Kim; Jae-Seok Kim; Hye Lim Hong; Jung Oak Kang; Jong Hee Shin; Yeon-Joon Park; Dongeun Yong; Seok Hoon Jeong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2011-09       Impact factor: 2.759

9.  How to measure hospital antibiotic consumption: comparison of two methods from data surveillance in France.

Authors:  Florence Stordeur; Katiuska Miliani; Ludivine Lacavé; Anne-Marie Rogues; Catherine Dumartin; Serge Alfandari; Pascal Astagneau; François L'Hériteau
Journal:  JAC Antimicrob Resist       Date:  2020-08-11

10.  Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship.

Authors:  Daniel Kwame Afriyie; Israel A Sefah; Jacqueline Sneddon; William Malcolm; Rachel McKinney; Lesley Cooper; Amanj Kurdi; Brian Godman; R Andrew Seaton
Journal:  JAC Antimicrob Resist       Date:  2020-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.